Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Barbaric, Ivana  [Clear All Filters]
2024
De Santis E, Faruqui N, Russell CT, Noble JE, Kepiro IE, Hammond K, Tsalenchuk M, Ryadnov EM, Wolna M, Frogley MD, et al. Hyperspectral Mapping of Human Primary and Stem Cells at Cell-Matrix Interfaces. ACS Appl Mater Interfaces. 2024.
Beltran-Rendon C, Price CJ, Glen K, Stacey A, Barbaric I, Thomas RJ. Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control. Cytotherapy. 2024.
2023
Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M, et al. ISSCR standards for the use of human stem cells in basic research. Stem Cell Reports. 2023;18(9):1744-1752.
2022
Baker D, Barbaric I. Characterizing the Genetic Stability of Human Naïve and Primed Pluripotent Stem Cells. Methods Mol Biol. 2022;2416:267-284.
Pernaute B, Pérez-Montero S, Nieto JMiguel Sá, Di Gregorio A, Lima A, Lawlor K, Bowling S, Liccardi G, Tomas A, Meier P, et al. DRP1 levels determine the apoptotic threshold during embryonic differentiation through a mitophagy-dependent mechanism. Dev Cell. 2022.
Steventon-Jones V, Stavish D, Halliwell JA, Baker D, Barbaric I. Single Nucleotide Polymorphism (SNP) Arrays and Their Sensitivity for Detection of Genetic Changes in Human Pluripotent Stem Cell Cultures. Curr Protoc. 2022;2(11):e606.
2021
Wu J, Barbaric I. Fitness selection in human pluripotent stem cells and interspecies chimeras: Implications for human development and regenerative medicine. Dev Biol. 2021.
Price CJ, Stavish D, Gokhale PJ, Stevenson BA, Sargeant S, Lacey J, Rodríguez TA, Barbaric I. Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition. Dev Cell. 2021.
2020
Thompson O, von Meyenn F, Hewitt Z, Alexander J, Wood A, Weightman R, Gregory S, Krueger F, Andrews S, Barbaric I, et al. Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions. Nat Commun. 2020;11(1):1528.
Halliwell JA, Frith TJR, Laing O, Price CJ, Bower OJ, Stavish D, Gokhale PJ, Hewitt Z, El-Khamisy SF, Barbaric I, et al. Nucleosides Rescue Replication-Mediated Genome Instability of Human Pluripotent Stem Cells. Stem Cell Reports. 2020.
Frith TJR, Gogolou A, Hackland JOS, Hewitt ZA, Moore HD, Barbaric I, Thapar N, Burns AJ, Andrews PW, Tsakiridis A, et al. Retinoic Acid Accelerates the Specification of Enteric Neural Progenitors from In-Vitro-Derived Neural Crest. Stem Cell Reports. 2020.
2019
Laing O, Halliwell J, Barbaric I. Rapid PCR Assay for Detecting Common Genetic Variants Arising in Human Pluripotent Stem Cell Cultures. Curr Protoc Stem Cell Biol. 2019:e83.
Stacey GN, Andrews PW, Barbaric I, Boiers C, Chandra A, Cossu G, Csontos L, Frith, Jr T, Halliwell JA, Hewitt Z, et al. Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform. Regen Med. 2019.